186
Participants
Start Date
November 2, 2022
Primary Completion Date
August 8, 2024
Study Completion Date
August 8, 2024
AV-101
AV-101 (imatinib) administered via dry powder inhalation
Azienda Ospedaliera Universitaria Policlinico Umberto I, Rome
Pauls Stradins Clinical University Hospital, Riga
Cliniques Universitaires de Bruxelles Hopital Erasme, Brussels
Universitaetsklinikum Carl Gustav Carus TU Dresden, Dresden
Cardiologia Palmero, Buenos Aires
Nexo Salud Investigación Clínica, Buenos Aires
Royal Prince Alfred Hospital, Camperdown
Center of Chest Disease Johannesburg, Johannesburg
UZ Leuven, Leuven
The Alfred Hospital, Melbourne
The Prince Charles Hospital, Chermside
Sunshine Coast University Hospital, Birtinya
Insituto Medico DAMIC, Córdoba
UPMC Presbyterian Hospital, Pittsburgh
GW Medical Faculty Associates, Washington D.C.
Ospedale San Giuseppe - Fatebenefratelli, Milan
Fondazione IRCCS San Gerardo Dei Tintori, Monza
Fondazione IRCCS Policlinico San Matteo, Pavia
Hospital 12 de Octubre, Madrid
Hospital Universitario Virgen de la Victoria, Málaga
Emory University, Atlanta
Mayo Clinic Florida, Jacksonville
Hopital Arnaud de Villeneuve, Montpellier
Hosp. Universitario Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria
Universitaetsklinikum Giessen und Marburg GmbH Standort Giessen, Giessen
Hospital universtario de Salamanca, Salamanca
Vanderbilt University Medical Center, Nashville
Hosp. Universitario Marques de Valdecilla, Santander
Chongqing Medical University - The First Affiliated Hospital, Chongqing
Ohio State University, Columbus
CICUM San Miguel, Guadalajara
Hospital Universitario de Toledo, Toledo
Indiana University Health, Indianapolis
University of Michigan, Ann Arbor
Washington University School of Medicine, St Louis
Unidad de Investigacion Clinica en Medicina S.C., Monterrey
Les Hôpitaux Universitaires de Strasbourg, Strasbourg
Universitaetsklinikum Heidelberg, Heidelberg
Azienda Ospedaliero Universitaria Ospedali Riuniti - Foggia, Foggia
Arizona Pulmonary Specialist. LTD., Phoenix
University of Arizona, Department of Medicine, Tucson
UCLA/David Geffen School of Medicine-Pulmonary and Criticial Care, Los Angeles
Kaiser Permanente - Los Angeles Medical Center, Los Angeles
Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione, Palermo
Hadassah University Hospital - Ein Kerem, Jerusalem
University of California, San Francisco
Groupement Hospitalier Sud - Hôpital Bicêtre, Le Kremlin-Bicêtre
UC Davis Medical Center, Sacramento
Peking Union Medical College Hospital, Beijing
National University Hospital, Singapore
Southeast University (SEU) - Zhongda Hospital, Nanjing
Tianjin Medical University General Hospital, Tianjin
Tan Tock Seng Hospital, Singapore
Central South University - The Second Xiangya Hospital, Hunan
Guangdong Provincial People's Hospital, Guangdong
Yanan Hospital of Kunming City, Kunming
Gansu Provincial People's Hospital, Lanzhou
Centro de Investigaciones Clinicas de la Universidad Catolica, Santiago
Tufts Medical Center, Inc., Boston
Sanatorio de la Trinidad Mitre, Buenos Aires
Hospital Dr. Jose Maria Cullen, Santa Fe
University of Alberta Hospital, Edmonton
London Health Science Centre, London
Jewish General Hospital, Montreal
Instituto Neumológico del Oriente S.A., Floridablanca
Krakowski Szpital Specjalistyczny im. Jana Pawla II, Krakow
Wojewódzki Specjalistyczny Szpital im. Dr. Wł. Biegańskiego w Łodzi, Lodz
Szpital Kliniczny Przemienienia Pańskiego UM im. Marcinkowskiego, Poznan
Hospital Garcia de Orta, EPE, Almada
Hospital Pulido Valente, Lisbon
Hospital Universitari Vall d'Hebron, Barcelona
Imperial College Healthcare NHS Trust, London
Lead Sponsor
Aerovate Therapeutics
INDUSTRY